DT56a stimulates gender-specific human cultured bone cells in vitro

Journal of Steroid Biochemistry and Molecular Biology

Volumn 98, Issue 1, 2006, Pages 90-96

  Somjen, Dalia ^a   Katzburg, Sara ^a   Lieberherr, M ^d   Hendel, David ^b   Yoles, Israel ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d CEMAGREF   (France)

Author keywords

Creatine kinase; DT56a; Estradiol; Human bone cells; Raloxifene

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATINE KINASE; DNA; DT 56A; ESTRADIOL; FEMARELLE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ARTICLE; BONE CELL; CALCIUM CELL LEVEL; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ANTAGONISM; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; OSTEOBLAST; POSTMENOPAUSE; SEX ROLE;

ALKALINE PHOSPHATASE; BONE AND BONES; BONE DENSITY; CALCIUM; CELLS, CULTURED; CREATINE KINASE; DNA; DRUG COMBINATIONS; ESTRADIOL; FEMALE; HUMANS; MALE; OSTEOBLASTS; PLANT EXTRACTS; POSTMENOPAUSE; PREMENOPAUSE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEX DISTRIBUTION;

EID: 30944457312     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.08.002     Document Type: Article

References (34)

1. B. Ettinger, H.K. Genant, and C.E. Cann Long-term estroge replacement therapy prevents bone loss and fractures Ann. Int. Med. 102 1985 319 324
2. S.C. Manolagas, S. Kousteni, and R.L. Jilka Sex steroids and bone Recent Prog. Horm. Res. 57 2002 385 409
3. D.P. McDonnell The molecular determinants of estrogen receptor pharmacology Maturitas 48S 2004 7 12
4. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, S. Nilsson, and J.A. Gustafsson Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta Endocrinology 138 1997 863 870
5. W. Shao, E.K. Keeton, D.P. McDonnell, and M. Brown Coactivator AIB1 links estrogen receptor transcriptional activity and stability Proc. Natl. Acad. Sci. U.S.A. 101 2004 11599 11604
6. A.H. Talukder, A. Gururaj, S.K. Mishra, R.K. Vadlamudi, and R. Kumar Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator Mol. Cell Biol. 424 2004 6581 6591
7. J.R. Pasqualini The selective estrogen enzyme modulators in breast cancer: a review Biochim. Biophys. Acta. 1654 2004 123 143
8. N. Morabito, A. Crisafulli, C. Vergara, A. Gaudio, A. Lasco, N. Frisina, R. D'Anna, F. Corrado, M.A. Pizzoleo, M. Cincotta, D. Altavilla, R. lentile, and F. Squadrito Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study J. Bone Miner. Res. 17 2002 1904 1912
9. H.J. Teede, B.P. McGrath, L. DeSilva, M. Cehun, A. Fassoulakis, and P.J. Nestel Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women Arterioscler. Thromb. Vasc. Biol. 23 2003 1066 1071
10. G. Tulipano, C. Bonfanti, C. Poiesi, A. Burattin, S. Turazzi, G. Barone, R. Cozzi, A. Bollati, D. Valle, and A. Giustina Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: in vitro studies Metabolism 53 2004 563 570
11. I.R. Reid, R. Eastell, I. Fogelman, J.D. Adachi, A. Rosen, C. Netelenbos, N.B. Watts, E. Seeman, A.V. Ciaccia, and M.W. Draper A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women Arch. Int. Med. 164 2004 871 879
12. M. Heringa Review on raloxifene: profile of a selective estrogen receptor modulator Int. J. Clin. Pharmacol. Ther. 41 2003 331 345
13. F. Cosman Selective estrogen-receptor modulators Clin. Geriatr. Med. 19 2003 371 379
14. S.D. Malnick, A. Shaer, H. Soreq, and A.M. Kaye Estrogen-induced creatine kinase in the reproductive system of the immature female rat Endocrinology 113 1983 1907 1909
15. D. Somjen, Y. Weisman, A. Harell, E. Berger, and A.M. Kaye Direct and sex specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone Proc. Natl. Acad. Sci. U.S.A. 86 1989 3361 3365
16. S. Katzburg, A. Ornoy, D. Hendel, M. Lieberherr, A.M. Kaye, and D. Somjen Age and gender specific stimulation of creatine kinase specific activity by gonadal steroids in human bone-derived cells in culture J. Endocrinol. Invest. 24 2001 166 172
17. D. Somjen, E. Knoll, F. Kohen, and N. Stern Effects of phytoestrogens on DNA synthesis and creatine kinase activity in vascular cells Am. J. Hypertens. 14 2001 256 1262
18. I. Yoles, Y. Yogev, Y. Frenkel, R. Nahum, M. Hirsch, and B. Kaplan Tofupill/Femarelle (DT56a) - a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss Menopause 10 2003 522 525
19. I. Yoles, Y. Yogev, Y. Frenkel, M. Hirsch, R. Nahum, and B. Kaplan Efficacy and safety of standard versus low-dose Femarelle (DT56a) for the treatment of menopausal symptoms Clin. Exp. Obstet. Gynecol. 31 2004 123 126
20. D. Somjen, and I. Yoles DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus J. Steroid. Biochem. Mol. Biol. 86 2003 93 98
21. D. Somjen, and I. Yoles DT56a stimulates creatine kinase specific activity in vascular tissues of rats J. Endocrinol. Invest. 26 2003 966 971
22. A.M. Kaye, M. Spatz, A. Waisman, S. Sasson, S. Tamir, J. Vaya, and D. Somjen Paradoxical interactions among estrogen receptors, estrogens and SERMS: mutual annihilation and synergy J. Steroid. Biochem. Mol. Biol. 76 2001 85 93
23. D. Somjen, A. Waisman, and A.M. Kaye Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo J. Steroid. Biochem. Mol. Biol. 59 1996 389 396
24. E. Berger, I. Bleiberg, Y. Weisman, A. Harel, A.M. Kaye, and D. Somjen Differentiation of cultured mice bone marrow into osteoblast-like cells results in acquisition of sex-specific responsiveness to gonadal steroids J. Endocr. Invest. 27 2004 622 629
25. D. Somjen, F. Kohen, and M. Lieberherr Nongenomic effects of anti-idiotypic antibody as an estrogen mimetic in human and rat female osteoblasts J. Cell. Biochem. 65 1997 53 66
26. D.N. Kalu The ovariectomized rat model of postmenopausal bone loss Bone Miner. 15 1991 175 191
27. T.J. Wronski, and C.F. Yen The ovariectomized rat model as an animal model for postmenopausal bone loss Cell Mat. 1 Suppl. 1991 69
28. H.M. Frost, and W.S. Jee On the rat model of human osteopenias and osteoporosis Bone Miner. 18 1992 227 236
29. A. Ornoy, and S. Katzburg Osteoporosis: animal models for the human disease A. Ornoy Animal Models of Human Related Calcium Metabolic Disorders 1995 CRC Press Florida, USA
30. I.U. Schmidt, G.K. Wakley, and R.T. Turner Effects of estrogen and progesterone on tibia histomorphometry in growing rats Calciff Tissue Int. 67 2000 47 52
31. T. Takamo-Yamamoto, and G.A. Rodan Direct effect of 17β-estradiol on trabecular bone in ovariectomized rats Proc. Natl. Acad. Sci. U.S.A. 87 1990 2172 2176
32. R. Turner, J.J. Vandersteenhoven, and N.H. Bell The effects of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats J. Miner. Res. 2 1987 115 122
33. M.J. Rogers New insights into the molecular mechanism of action of bisphosphonates Curr. Pharm. Des. 9 2003 2643 2658
34. S.L. Teitelbaum, M.M. Tondravi, and F.P. Ross Osteoclasts, macrophages, and the molecular mechanisms of bone resorption J. Leukoc. Biol. 61 1997 381 388